MCID: BRS001
MIFTS: 32

Breast Lymphoma malady

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Breast Lymphoma

Aliases & Descriptions for Breast Lymphoma:

Name: Breast Lymphoma 12 14 69
Malignant Lymphoma of Breast 12
Lymphoma of the Breast 12
Lymphoma of Breast 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5826
SNOMED-CT 64 278052009
UMLS 69 C0349669

Summaries for Breast Lymphoma

MalaCards based summary : Breast Lymphoma, also known as malignant lymphoma of breast, is related to lymphoma and hyperandrogenism. An important gene associated with Breast Lymphoma is PIBF1 (Progesterone Immunomodulatory Binding Factor 1). The drugs Dermatologic Agents and Doxorubicin have been mentioned in the context of this disorder. Affiliated tissues include breast, b cells and bone.

Related Diseases for Breast Lymphoma

Graphical network of the top 20 diseases related to Breast Lymphoma:



Diseases related to Breast Lymphoma

Symptoms & Phenotypes for Breast Lymphoma

Drugs & Therapeutics for Breast Lymphoma

Drugs for Breast Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 393)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2
2
Doxorubicin Approved, Investigational Phase 2, Phase 3, Phase 1 23214-92-8 31703
3
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
4
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
5
Melphalan Approved Phase 3,Phase 1,Phase 2 148-82-3 4053 460612
6
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
7
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
8
Oxaliplatin Approved, Investigational Phase 2, Phase 3 61825-94-3 5310940 9887054 6857599, 9887054 43805
9
Everolimus Approved Phase 3,Phase 1,Phase 2 159351-69-6 6442177
10
Capecitabine Approved, Investigational Phase 2, Phase 3,Phase 1 154361-50-9 60953
11
Sirolimus Approved, Investigational Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
12
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
13
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
14
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
15
Tamoxifen Approved Phase 3,Phase 2 10540-29-1 2733526
16
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
17
Mycophenolic acid Approved Phase 3,Phase 1,Phase 2 24280-93-1 446541
18
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 1,Phase 2 128794-94-5 5281078
19
Fludarabine Approved Phase 3,Phase 1,Phase 2 21679-14-1, 75607-67-9 30751
20
Captopril Approved Phase 3 62571-86-2 44093
21
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
22
Ribavirin Approved Phase 3 36791-04-5 37542
23
Fluconazole Approved Phase 3 86386-73-4 3365
24
rituximab Approved Phase 3,Phase 2,Phase 1 174722-31-7 10201696
25
Zoledronic acid Approved Phase 3 118072-93-8 68740
26
Mechlorethamine Approved Phase 3,Phase 1 51-75-2 4033
27
Denosumab Approved Phase 3,Phase 2 615258-40-7
28
Ofloxacin Approved Phase 3 82419-36-1 4583
29
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
30
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
31
Fluorouracil Approved Phase 2, Phase 3 51-21-8 3385
32
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
33
Carmustine Approved Phase 3,Phase 2 154-93-8 2578
34
Palivizumab Approved, Investigational Phase 3 188039-54-5
35
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
36
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
37
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
38
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
39
Estradiol Approved, Investigational, Vet_approved Phase 3,Phase 1 50-28-2 5757 53477783
40
Daunorubicin Approved Phase 3 20830-81-3 30323
41
Topotecan Approved, Investigational Phase 2, Phase 3 119413-54-6, 123948-87-8 60700
42
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
43
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
44
Gemcitabine Approved Phase 3,Phase 2,Phase 1 95058-81-4 60750
45
Succinylcholine Approved Phase 3,Phase 2 306-40-1 5314
46
Goserelin Approved Phase 3 65807-02-5 47725 5311128
47
Vidarabine Approved Phase 3,Phase 2,Phase 1 24356-66-9 32326 21704
48
Leuprolide Approved, Investigational Phase 3 53714-56-0 3911 657181
49
Fulvestrant Approved, Investigational Phase 3,Phase 1 129453-61-8 104741 17756771
50
Exemestane Approved, Investigational Phase 3,Phase 1 107868-30-4 60198

Interventional clinical trials:

(show top 50) (show all 294)
id Name Status NCT ID Phase
1 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Completed NCT00277160 Phase 4
2 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Recruiting NCT02905916 Phase 4
3 Assessment and Tracking of Long-term Alefacept Safety Terminated NCT00454701 Phase 4
4 Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis Completed NCT00243685 Phase 2, Phase 3
5 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3
6 Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women Completed NCT01052051 Phase 3
7 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. Completed NCT00330759 Phase 3
8 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
9 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
10 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
11 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
12 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
13 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
14 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
15 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy Completed NCT00270166 Phase 3
16 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy Completed NCT00003600 Phase 3
17 Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma. Recruiting NCT02964858 Phase 3
18 Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Recruiting NCT01901094 Phase 3
19 Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Recruiting NCT02443077 Phase 3
20 Breast Cancer WEight Loss Study (BWEL Study) Recruiting NCT02750826 Phase 3
21 S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Recruiting NCT01674140 Phase 3
22 Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Recruiting NCT02927249 Phase 3
23 Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Recruiting NCT01272037 Phase 3
24 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Recruiting NCT01953588 Phase 3
25 Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Recruiting NCT02201992 Phase 3
26 Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) Recruiting NCT02704832 Phase 3
27 Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Recruiting NCT02003222 Phase 3
28 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Recruiting NCT02516423 Phase 3
29 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Recruiting NCT00565851 Phase 3
30 Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Recruiting NCT02193282 Phase 3
31 PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Recruiting NCT01515787 Phase 2, Phase 3
32 Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Recruiting NCT01575548 Phase 3
33 Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Recruiting NCT01101451 Phase 3
34 Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Recruiting NCT00632853 Phase 3
35 S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Recruiting NCT02438722 Phase 2, Phase 3
36 Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Recruiting NCT02101788 Phase 2, Phase 3
37 High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery Recruiting NCT02506153 Phase 3
38 A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) Active, not recruiting NCT01332968 Phase 3
39 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Active, not recruiting NCT00004179 Phase 3
40 Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Active, not recruiting NCT02048813 Phase 3
41 Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Active, not recruiting NCT00499330 Phase 3
42 Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan Available NCT01777061 Phase 3
43 Methylphenidate Study in Breast or Gastrointestinal Cancer Patients Terminated NCT00516269 Phase 3
44 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3
45 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3
46 A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Unknown status NCT01065805 Phase 1, Phase 2
47 Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans Unknown status NCT02340845 Phase 2
48 Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor Unknown status NCT01175096 Phase 1, Phase 2
49 Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia Unknown status NCT00271063 Phase 1, Phase 2
50 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2

Search NIH Clinical Center for Breast Lymphoma

Genetic Tests for Breast Lymphoma

Anatomical Context for Breast Lymphoma

MalaCards organs/tissues related to Breast Lymphoma:

39
Breast, B Cells, Bone, Bone Marrow, Lymph Node, Skin, Ovary

Publications for Breast Lymphoma

Articles related to Breast Lymphoma:

(show top 50) (show all 133)
id Title Authors Year
1
Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature. ( 27225235 )
2016
2
Breast Lymphoma Treatment Outcomes in a Pakistani Population: 20 Years of Experience at a Single Center. ( 27510022 )
2016
3
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group. ( 27847267 )
2016
4
Sonoelastography of Breast Lymphoma. ( 26808169 )
2016
5
Primary Breast Lymphoma in a Woman: A Case Report and Review of the Literature. ( 26893404 )
2016
6
Primary breast lymphoma presenting as non-healing axillary abscess. ( 26446318 )
2015
7
F-18 FDG PET/MRI findings of primary breast lymphoma in two cases: FDG PET/MRI findings of primary breast lymphoma. ( 25748090 )
2015
8
MRI features of breast lymphoma: preliminary experience in seven cases. ( 26380896 )
2015
9
Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature. ( 25572809 )
2015
10
Report of a case of primary breast lymphoma highlighting the importance of fine needle aspiration cytology as an initial diagnostic tool. ( 26229252 )
2015
11
Primary breast lymphoma with progression to the scalp. ( 26458702 )
2015
12
First pathological study of canine primary breast lymphoma and the description of its clinicopathological characteristics as an animal model for human primary breast lymphoma. ( 25469251 )
2015
13
Primary breast lymphoma. ( 24953564 )
2014
14
Primary breast lymphoma: 30 years of experience with diagnosis and treatment at a single medical center. ( 24257833 )
2014
15
Synchronous breast cancer and breast lymphoma: two case reports and literature review. ( 25035665 )
2014
16
Isolated cerebellar hypermetabolism on FDG PET in a case of remitted primary breast lymphoma. ( 24591788 )
2014
17
Breast lymphoma combined with postoperative acute hematopoietic disorder in an immediate breast reconstruction patient. ( 24491455 )
2014
18
Primary breast lymphoma: A single-institute experience in Taiwan. ( 25179707 )
2014
19
Primary breast lymphoma: a single institution's experience. ( 23646311 )
2013
20
Three Cases of Combined Therapy in Primary Breast Lymphoma (PBL) with Successful Outcomes. ( 23885182 )
2013
21
Cytodiagnosis of the primary breast lymphoma in a young woman. ( 24648678 )
2013
22
Primary breast lymphoma in males-a report of two cases with a review of the literature. ( 24723970 )
2013
23
Primary breast lymphoma. ( 23906238 )
2013
24
Breast lymphoma presenting as gynecomastia in male patient. ( 23815269 )
2013
25
Unusual breast neoplasm: primary breast lymphoma. ( 23749857 )
2013
26
Primary diffuse large B-cell lymphoma of the nipple: a rare case of breast lymphoma localized in the nipple. ( 23316783 )
2013
27
MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review. ( 23846235 )
2013
28
Bilateral primary breast lymphoma in a teenage girl with multi-organ involvement. ( 24026996 )
2013
29
The features of breast lymphoma on MRI. ( 24029630 )
2013
30
Treatment and outcomes of primary breast lymphoma. ( 23018097 )
2012
31
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. ( 22665932 )
2012
32
Primary breast lymphoma sequentially relapsed in the peripheral and central nervous system. ( 22426680 )
2012
33
Synchronous bilateral primary breast lymphoma. ( 22616682 )
2012
34
Fusion PET-CT detection of neurolymphomatosis originating from primary breast lymphoma: A case report and literature review. ( 23162634 )
2012
35
Primary breast lymphoma with sudden death. ( 21512383 )
2011
36
Primary breast lymphoma clinically mimicking acute mastitis: a case report. ( 21617722 )
2011
37
Breast lymphoma complicating anti-tumor necrosis factor therapy in rheumatoid arthritis. ( 21729669 )
2011
38
A rare case of Hodgkin's breast lymphoma masquerading as locally advanced breast carcinoma. ( 21330757 )
2011
39
Primary breast lymphoma - a review of the literature and report of three cases. ( 22291729 )
2011
40
Analysis of 31 cases of primary breast lymphoma: the effect of nodal involvement and microvascular density. ( 21454188 )
2011
41
A rare case of male primary breast lymphoma. ( 22323922 )
2011
42
Infiltrating ductal carcinoma of the breast associated with primary breast lymphoma. ( 21475637 )
2011
43
Primary breast lymphoma: a rare entity. ( 22470790 )
2011
44
A mimic of breast lymphoma: extranodal Rosai-Dorfman disease. ( 20220338 )
2010
45
Bilateral primary breast lymphoma masquerading as lactating mastitis. ( 20728042 )
2010
46
Primary breast lymphoma after mastectomy with reconstruction. ( 20705567 )
2010
47
Bilateral primary breast lymphoma. ( 20819615 )
2010
48
Breast lymphoma in SjAPgren's syndrome complicated by acute monocular blindness. ( 20536602 )
2010
49
F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report. ( 20727168 )
2010
50
Magnetic resonance imaging of primary breast lymphoma. ( 19562266 )
2009

Variations for Breast Lymphoma

Expression for Breast Lymphoma

Search GEO for disease gene expression data for Breast Lymphoma.

Pathways for Breast Lymphoma

GO Terms for Breast Lymphoma

Sources for Breast Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....